Insulin secretion and sensitivity in patients with secondary failure to oral hypoglycemic drugs Secrecion y sensibilidad insulinica en el fracaso secundario a drogas hipoglicemiantes orales.
Author
dc.contributor.author
López López, J. A.
Author
dc.contributor.author
Calvillán,
Author
dc.contributor.author
Durruty, P.
Author
dc.contributor.author
Rocha,
Admission date
dc.date.accessioned
2019-01-29T14:51:10Z
Available date
dc.date.available
2019-01-29T14:51:10Z
Publication date
dc.date.issued
1992
Cita de ítem
dc.identifier.citation
Revista medica de Chile, Volumen 120, Issue 9, 2018, Pages 969-977
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/160935
Abstract
dc.description.abstract
Secretion and peripheral sensitivity to insulin was investigated in diabetic patients with secondary failure to oral hypoglycemic drugs. 8 patients with secondary failure (non responders), 7 non insulin dependent diabetic patients with good response to oral drugs (responders) and 8 control subjects were studied. Insulin secretion was determined with peptide C in urine obtained 4h after a 500 Cal breakfast; in vivo insulin sensitivity was studied by the euglycemic hyperinsulinemic clamp technique. All groups were comparable in age, nutritional status and duration of diabetes. Non responders had higher fasting blood sugar levels compared to responders (228 +/- 70 vs 136 +/- 21 mg/dl, p < 0.05). Controls had lower blood sugar levels than the other 2 groups (93 +/- 8, p < 0.05). Insulin levels were similar in non responders and responders (24 +/- 12 and 16 +/- 9 uU/ml, respectively) and higher than in controls (10 +/- 3, p < 0.05). Peptide C was lower in non responders than in responders (
Insulin secretion and sensitivity in patients with secondary failure to oral hypoglycemic drugs Secrecion y sensibilidad insulinica en el fracaso secundario a drogas hipoglicemiantes orales.